NDC 60940-029

Triferic AVNU

Ferric Pyrophosphate Citrate

Triferic AVNU is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Holopack Verpackungstechnik Gmgh. The primary component is Ferric Pyrophosphate Citrate.

Product ID60940-029_cf6efa8f-5129-cd0b-e053-2995a90a71d8
NDC60940-029
Product TypeHuman Prescription Drug
Proprietary NameTriferic AVNU
Generic NameFerric Pyrophosphate Citrate
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-06-02
Marketing CategoryNDA /
Application NumberNDA212860
Labeler NameHolopack Verpackungstechnik GmgH
Substance NameFERRIC PYROPHOSPHATE CITRATE
Active Ingredient Strength2 mg/mL
Pharm ClassesIron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 60940-029-01

4 POUCH in 1 CARTON (60940-029-01) > 10 AMPULE in 1 POUCH > 4.5 mL in 1 AMPULE
Marketing Start Date2020-06-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Triferic AVNU" or generic name "Ferric Pyrophosphate Citrate"

NDCBrand NameGeneric Name
57278-318Triferic AVNUferric pyrophosphate citrate
60940-029Triferic AVNUferric pyrophosphate citrate
57278-315TrifericFERRIC PYROPHOSPHATE CITRATE
57278-316TrifericFerric Pyrophosphate Citrate
64811-315TrifericFERRIC PYROPHOSPHATE CITRATE
60940-022Triferic Solution for Hemodialysisferric pyrophosphate citrate

Trademark Results [Triferic AVNU]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRIFERIC AVNU
TRIFERIC AVNU
88902817 not registered Live/Pending
ROCKWELL MEDICAL, INC.
2020-05-06
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.